Home / Data / Recall & Adverse Event Monitor Recall & Adverse Event Monitor Recall & Adverse Event Monitor organizes records from openFDA API into a static ledger for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 2,000
Last changed 08/30/2026
Update schedule 28 2 * * 4 UTC
Coverage 06/30/2026–06/30/2026 2026-06-30
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title USTEKINUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title UPTRAVI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CARBOPLATIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CARBOPLATIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title FENTANYL
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title PACLITAXEL
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title MYCAPSSA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VENETOCLAX
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TRESIBA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SKYRIZI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OMALIZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title COBENFY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SKYRIZI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CAMZYOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYSABRI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title METFORMIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RAVULIZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title REBLOZYL
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title METFORMIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RYBELSUS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title METFORMIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title PALIPERIDONE PALMITATE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title HEMLIBRA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title INFLIXIMAB-DYYB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ATORVASTATIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VYLOY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TRAMADOL
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SERTRALINE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CARBIDOPA\LEVODOPA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SYNTHROID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NUPLAZID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title IMAAVY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24 Source U.S. Food and Drug Administration, openFDA API · official record · retrieved 08/30/2026 · upstream last modified 08/30/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. Food and Drug Administration
Required notice Reports do not prove causation and are not medical advice, diagnosis, or an assessment of individual risk. What we add We compute Event Classification, Age Or Deadline Days, Public Significance Score using the documented compute method. · methodology